ABUS
#2452
Arbutus Biopharma Corporation - Common Stock
5.0 7 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.93%
Variación mensual
+15.23%
Variación en los últimos 6 meses
+11.67%
Cambio anual
+37.40%
Cierres anteriores
5.1 7
Open
5.0 7
Mínimo
5.0 7
Máximo
5.0 7
Volumen
94
Financials
- Market Capitalization 1 B
- Employee 19
- Founded 2007
- CEO William H. Collier
- Website www.arbutusbio.com
- Headquarter British Columbia, Canada
- FIGI BBG000RR8V85
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
6.08
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2426 |  SLDB Solid Biosciences Inc. - Common Stock | 9.77 USD | -3.55% | +5.28% | +15.21% | +71.40% | 1.05 B USD | ||
| 2441 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.29 USD | -1.29% | -1.29% | -1.29% | +104.46% | 1.02 B USD | ||
| 2453 |  CADL Candel Therapeutics, Inc. - Common Stock | 13.07 USD | -4.95% | +0.69% | +31.36% | +124.96% | 1.00 B USD | ||
| 2456 |  IMMX Immix Biopharma, Inc. - Common Stock | 13.94 USD | -2.59% | +2.05% | +61.90% | +530.77% | 997.26 M USD |